Pharmacological study of 2-ethyl-4-ethylamino-6-methoxy-s-triazine, a new compound with both central sympathetic and parasympathetic stimulating properties.
D000588:Amines / Q000032:analysis; D000818:Animals; D001341:Autonomic Nervous System / Q000187:drug effects*; D001522:Behavior, Animal / Q000187:drug effects*; D001794:Blood Pressure / Q000187:drug effects; D001923:Brain Chemistry / Q000187:drug effects; D002319:Cardiovascular System / Q000187:drug effects*; D002415:Cats; D002490:Central Nervous System / Q000187:drug effects*; D002707:Chlordiazepoxide / Q000494:pharmacology; D002746:Chlorpromazine / Q000494:pharmacology; D004285:Dogs; D004569:Electroencephalography; D005260:Female; D005730:Ganglionic Blockers / Q000494:pharmacology; D000882:Haplorhini; D006339:Heart Rate / Q000187:drug effects; D066298:In Vitro Techniques; D008297:Male; D051379:Mice; D009541:Nictitating Membrane / Q000187:drug effects; D010276:Parasympatholytics / Q000494:pharmacology; D010277:Parasympathomimetics / Q000494:pharmacology; D011817:Rabbits; D051381:Rats; D012018:Reflex / Q000187:drug effects; D012119:Respiration / Q000187:drug effects*; D012472:Salivation / Q000187:drug effects; D013268:Stimulation, Chemical; D013565:Sympatholytics / Q000494:pharmacology; D013566:Sympathomimetics / Q000494:pharmacology; D014227:Triazines / Q000037:antagonists & inhibitors / Q000494:pharmacology* / Q000633:toxicity; D014665:Vasodilator Agents / Q000494:pharmacology
D000588:Amines; D005730:Ganglionic Blockers; D010276:Parasympatholytics; D010277:Parasympathomimetics; D013565:Sympatholytics; D013566:Sympathomimetics; D014227:Triazines; D014665:Vasodilator Agents; D002707:Chlordiazepoxide; D002746:Chlorpromazine